Yes, I recall a similar thing about this time last year.
We back tracked to Akida 1000 getting 5-6 licences (including Megachips sub licenses) within 18 months of the IP being available.
On that assumption and Akida 2000 being better placed for the market, that takes us to ??? Well not sure there as BRN had Ann’s on it ranging from March to Oct. Was it general availability to EAP’s then to the broader market in Oct 2023? I would argue that it was as clear as mud the way it was explained through the ASX.
At the worst you could say to date that EAPs have had 18months of Akida 2000 eval with 1500 and 500 on the side..
By linear measures above, one could say a better product shouldn’t take longer to get IP signings, yet Antonio Viana’s caution says the evaluation cycle could be longer..
In that time our CEO has presented the 5 year plan with the ecosystem buildout and agressive sales acceleration efforts. One could again assume that with more resources at your disposal, a better product, and paying market rates for quality personnel, that BRN have positioned themselves perfectly to disrupt the market.
These were the thoughts coming into 2024. High expectations..
Fast forward to now, with three highly regarded Sales and Marketing people having left the company in Chris Stevens, Nandan, and Rob Telson, it’s difficult to find rationale as to why these people would leave Brainchip at such a time.
Couple that with what the company is saying that they expect more in terms of commercial execution, then the question still begs, is it Sean as CEO that has the fish rotting at the head, is it Antonio’s thesis that it will just take a lot more time, or is it the product that isn’t actually as good as is promoted?
The ironic thing is there could be an element of truth in all 3 of those points..
Even the most ardent of supporters are seemingly unhappy with Brainchips lack of execution commercially this year which says to me that maybe it is management that are performing poorly. Many of these shareholders likely having met management at private presentations and had more contact with management than your standard report reading, Google researching shareholder that is less hands on with their research.
Time will tell, however there seem to be many who are expecting good things by early 2025, for whatever secret reasons they can’t share. I look at the Socials and the ASX Reports and there’s nothing that can distinguish “it’s actually happpening now” vs last time in 2021/2022. The only measure in the buying and selling of shares is showing more potential now than in 2022 & 2023, so is it just the usual positive BRN seasonality of Oct- January, or is it happening..
What say you?
Expand
(20min delay)